Literature DB >> 12548599

R-Ras promotes tumor growth of cervical epithelial cells.

Héctor Rincón-Arano1, Ricardo Rosales, Nancy Mora, Armando Rodriguez-Castañeda, Carlos Rosales.   

Abstract

BACKGROUND: R-Ras is 55% identical to H-Ras. However, these two oncogenes seem to have different tumor-transforming potential. R-Ras induced cell transformation in fibroblasts but not in other cell types. R-Ras also reportedly induces a more invasive phenotype in breast epithelial cells through integrin activation. The authors studied the mechanisms whereby R-Ras induces a malignant phenotype.
METHODS: Dominant negative (R-Ras43N) and constitutively active (R-Ras87L) mutants of R-Ras were stably transfected into human cervical epithelium C33A cells. Transfected cells were analyzed for adhesion, cell spreading, migration, and growth in culture and in nude mice. The activity of extracellular signal-regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI 3-K) also was determined by Western blot analysis and by in vitro kinase assays.
RESULTS: R-Ras87L-transfected cells, but not R-Ras43 N-transfected cells, had a higher growth rate in nude mice and in culture compared with control cells. None of the transfected C33A cells showed an increase in cell adhesion to fibronectin or collagen I, nor did they show an increment of beta1 integrin affinity. However, cells that expressed R-Ras87L, but not cells that expressed R-Ras 43N, presented a marked increase in cell spreading and migration through collagen-coated membranes. Increases in cell proliferation, spreading, and migration induced by R-Ras87L were inhibited by the PI 3-K inhibitor LY294002. In addition, PI 3-K activity, but not ERK activity, was increased only in cells that expressed R-Ras87L.
CONCLUSIONS: These data suggest that the oncogene R-Ras promotes tumor growth of cervical epithelial cells and increases their migration potential over collagen through a pathway that involves PI 3-K. Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11093

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548599     DOI: 10.1002/cncr.11093

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  R-Ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho.

Authors:  Michele A Wozniak; Lina Kwong; David Chodniewicz; Richard L Klemke; Patricia J Keely
Journal:  Mol Biol Cell       Date:  2004-11-03       Impact factor: 4.138

2.  H-Ras, R-Ras, and TC21 differentially regulate ureteric bud cell branching morphogenesis.

Authors:  Ambra Pozzi; Sergio Coffa; Nada Bulus; Wenqin Zhu; Dong Chen; Xiwu Chen; Glenda Mernaugh; Yan Su; Songmin Cai; Amar Singh; Marcela Brissova; Roy Zent
Journal:  Mol Biol Cell       Date:  2006-02-08       Impact factor: 4.138

3.  FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus.

Authors:  Jian-Sheng Wang; Jing-Sen Shi; Yi-Zhuang Xu; Xiao-Yi Duan; Li Zhang; Jing Wang; Li-Ming Yang; Shi-Fu Weng; Jin-Guang Wu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  R-Ras protein inhibits autophosphorylation of vascular endothelial growth factor receptor 2 in endothelial cells and suppresses receptor activation in tumor vasculature.

Authors:  Junko Sawada; Fangfei Li; Masanobu Komatsu
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

5.  EphB2/R-Ras signaling regulates glioma cell adhesion, growth, and invasion.

Authors:  Mitsutoshi Nakada; Jared A Niska; Nhan L Tran; Wendy S McDonough; Michael E Berens
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

6.  Notch1-mediated tumor suppression in cervical cancer with the involvement of SST signaling and its application in enhanced SSTR-targeted therapeutics.

Authors:  Laura G Franko-Tobin; L Vienna Mackey; Wei Huang; Xiangwei Song; Baofeng Jin; Jing Luo; Lynsie M Morris; Minqiu Liu; Joseph A Fuselier; David H Coy; Lizi Wu; Lichun Sun
Journal:  Oncologist       Date:  2012-01-30

7.  R-Ras regulates migration through an interaction with filamin A in melanoma cells.

Authors:  Joanna E Gawecka; Genevieve S Griffiths; Barbro Ek-Rylander; Joe W Ramos; Michelle L Matter
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

8.  Mutations in PIK3CA are infrequent in neuroblastoma.

Authors:  Vincent Dam; Brian T Morgan; Pavel Mazanek; Michael D Hogarty
Journal:  BMC Cancer       Date:  2006-07-05       Impact factor: 4.430

9.  Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells.

Authors:  G M Argast; C H Croy; K L Couts; Z Zhang; E Litman; D C Chan; N G Ahn
Journal:  Oncogene       Date:  2009-06-01       Impact factor: 9.867

Review 10.  The Role of R-Ras Proteins in Normal and Pathologic Migration and Morphologic Change.

Authors:  Shannon M Weber; Steven L Carroll
Journal:  Am J Pathol       Date:  2021-06-07       Impact factor: 5.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.